Ligand validation:3UKH

GDU: GALACTOSE-URIDINE-5'-DIPHOSPHATE

GDU is a Ligand Of Interest in 3UKH designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3UKH_GDU_C_521	4%	15%	0.465	0.849	1.94	1.81	11	10	7	0	100%	0.55
3UKH_GDU_G_521	3%	15%	0.406	0.732	1.92	1.85	11	11	7	0	100%	0.56
3UKH_GDU_H_521	2%	15%	0.571	0.816	1.96	1.84	10	10	10	0	100%	0.57
3UKH_GDU_D_521	1%	15%	0.534	0.669	1.93	1.87	11	11	4	0	100%	0.51
3UKH_GDU_B_521	0%	15%	0.582	0.641	1.94	1.84	11	10	10	0	100%	0.49
3UKH_GDU_E_521	0%	13%	0.578	0.622	1.91	2.03	10	15	10	0	100%	0.45
3UKH_GDU_A_521	0%	15%	0.668	0.665	1.92	1.84	10	11	10	0	100%	0.49
3UKH_GDU_F_521	0%	15%	0.711	0.548	1.92	1.85	11	10	3	0	100%	0.51
3UKF_GDU_H_802	100%	14%	0.043	0.992	1.94	1.89	12	10	3	0	100%	1
3UKP_GDU_D_602	65%	13%	0.151	0.953	2.03	1.96	9	15	3	0	100%	1
3UTH_GDU_A_514	57%	18%	0.172	0.949	1.73	1.8	10	15	6	0	100%	0.76
3UKQ_GDU_A_602	23%	14%	0.253	0.878	1.87	1.95	11	14	1	0	100%	1
4HO9_GDU_B_300	99%	24%	0.05	0.983	1.38	1.71	4	9	0	0	100%	1
6GX0_GDU_A_402	97%	47%	0.067	0.98	0.81	1.22	1	6	0	0	100%	0.6
5M7D_GDU_A_402	97%	44%	0.071	0.983	0.91	1.26	1	6	0	0	100%	1
7YS9_GDU_A_404	91%	78%	0.087	0.974	0.39	0.51	-	1	1	0	100%	0.4
4LW3_GDU_A_402	89%	11%	0.104	0.983	2.67	1.52	15	10	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.